BILATERAL BREAST CARCINOMA
Clinical trials for BILATERAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILATERAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for BILATERAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine aims to block return of aggressive breast cancer
Disease control OngoingThis phase 2 trial tests whether a vaccine made from a protein found on many triple-negative breast cancer cells can help prevent the cancer from coming back. Participants receive the vaccine along with an immune booster and a low dose of chemotherapy. The study includes women wi…
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a new drug help when standard chemo leaves cancer behind?
Disease control OngoingThis study tests whether the drug ixabepilone can help people with HER2-negative breast cancer who still have significant cancer after standard chemotherapy. About 116 participants will either receive ixabepilone or standard care. The goal is to see if ixabepilone improves outcom…
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control OngoingThis early-stage trial tests a drug called berzosertib combined with radiation therapy for people with certain types of breast cancer that no longer respond to chemotherapy. The goal is to find the safest dose and see if the combination can shrink or stabilize tumors better than …
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC